abstract |
The present invention relates to an immunogenic composition comprising S. pneumoniae capsular saccharide conjugates derived from serotypes 19A and 19F, wherein 19A is conjugated to a first bacterial toxoid and 19F is a second bacterial toxoid. Disclosed is the composition as conjugated to Also described are vaccines, methods of making the vaccines, and uses of the vaccines. |